Shortage Of Antimicrobial Agents Used In Tuberculosis (Tb) Treatment

Posted on:

The following antimicrobial medicines used to treat
tuberculosis (TB) will be intermittently available until at least the end of
2025:

  • Rifampicin 150mg and 300mg
    capsules
  • Rifampicin 600mg IV
    solution for infusion
  • Rifampicin 100mg/5ml oral suspension
  • Rifinah® 300
    tablets (rifampicin 300mg / isoniazid 150mg)
  • Rifater®
    tablets (rifampicin 120mg / isoniazid 50mg/ pyrazinamide 300mg)
  • Voractiv®
    tablets (rifampicin 150mg/ isoniazid 75mg / pyrazinamide 400mg / ethambutol
    275mg)
  • Pyrazinamide 500mg tablets

Ethambutol tablets, Isoniazid tablets, and Rifinah® 150 tablets (rifampicin 150?mg / isoniazid 100?mg) and Mycobutin® (rifabutin) 150mg capsules remain available but cannot support a full increase in demand.

This National Patient Safety Alert provides further background, clinical information and actions for providers.

This website is for healthcare professions only.

It is not for public use.

Feedback
Feedback
How would you rate your experience?
Do you have any additional comment?
Next
Enter your email if you'd like us to contact you regarding with your feedback.
Back
Submit
Thank you for submitting your feedback!